InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by NEWHALL CHARLES W III, Director. Insider active across 1 companies, notably Supernus Pharmaceuticals, INC.. In total, 3 reports have been logged. Total volume traded: €2.1m. The latest transaction was disclosed on 9 October 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
US$1m23,800 shares@ US$43.85960.037% mcap100.0% of flow
Common Stock
SEC:0001628280-25-044797·
€1m23,800 shares@ €43.85960.037% mcap50.0% of flow
Common Stock
SEC:0001628280-25-044797:0·
04,222 shares0
Common Stock
SEC:0001104659-22-026109:0·
3 of 3 declarations
About NEWHALL CHARLES W III
Charles W. Newhall III is a Director of SUPERNUS PHARMACEUTICALS, INC. He plays a key role in the strategic direction of the company, ensuring that decisions made align with growth and innovation objectives.
